Akso Health Group (AHG)
NASDAQ: AHG · Real-Time Price · USD
0.8480
-0.0258 (-2.95%)
At close: Sep 4, 2026, 4:00 PM EDT
0.9120
+0.0640 (7.55%)
After-hours: Sep 4, 2026, 7:30 PM EDT

Akso Health Group Balance Sheet

Millions USD. Fiscal year is Apr - Mar.

Assets

Fiscal Quarter
Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Cash & Equivalents
0.170.1711.1311.13176.23176.2391.3791.3785.1785.17
Cash & Short-Term Investments
0.170.1711.1311.13176.23176.2391.3791.3785.1785.17
Cash Growth (YoY)
-99.90%-99.90%-87.82%-87.82%106.91%106.91%886.32%886.32%--
Accounts Receivable
1.281.283.173.170.950.950.410.41--
Receivables
1.281.285.875.8712.912.90.410.41--
Inventory
0.20.20.190.190.190.190.20.20.190.19
Other Current Assets
187.89187.891.21.26.816.818.248.2456.6556.65
Total Current Assets
189.55189.5518.3918.39196.12196.12100.21100.21142.02142.02
Property, Plant & Equipment
0.030.030.090.090.110.110.240.24--
Goodwill
--11.0411.0410.8310.83112.5112.5--
Other Intangible Assets
0.060.066.856.857.887.88----
Other Long-Term Assets
--175.66175.66------
Total Assets
189.63189.63212.04212.04214.95214.95212.95212.95142.02142.02

Liabilities

Fiscal Quarter
Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Accounts Payable
------0.260.26--
Accrued Expenses
1.841.841.741.741.461.461.291.291.091.09
Short-Term Debt
2.352.3522226.656.6522
Current Portion of Leases
0.020.020.040.040.040.040.040.04--
Current Income Taxes Payable
0.090.090.240.240.090.090.130.130.090.09
Other Current Liabilities
4.414.417.997.9910.2210.223.863.860.420.42
Total Current Liabilities
8.718.7112.0212.0213.8113.8112.2312.233.593.59
Long-Term Leases
000.020.020.040.040.060.06--
Long-Term Deferred Tax Liabilities
--1.691.691.951.95----
Total Liabilities
8.718.7113.7313.7315.815.812.312.33.593.59

Shareholders' Equity

Fiscal Quarter
Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Common Stock
0.260.260.260.260.170.170.070.070.040.04
Additional Paid-In Capital
405.53405.53405.53405.53405.62405.62273.05273.05210.32210.32
Retained Earnings
-217.58-217.58-200.18-200.18-198.9-198.9-64.51-64.51-63.93-63.93
Treasury Stock
-3.99-3.99-3.99-3.99-3.99-3.99-3.99-3.99-3.99-3.99
Comprehensive Income & Other
-3.28-3.28-3.31-3.31-3.77-3.77-4.06-4.06-4.09-4.09
Total Common Equity
180.93180.93198.3198.3199.12199.12200.56200.56138.37138.37
Minority Interest
-0.01-0.010.010.010.030.030.090.090.060.06
Shareholders' Equity
180.92180.92198.31198.31199.15199.15200.65200.65138.42138.42
Total Liabilities & Equity
189.63189.63212.04212.04214.95214.95212.95212.95142.02142.02

Additional Metrics

Fiscal Quarter
Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Total Debt
2.382.382.062.062.082.086.756.7522
Net Cash (Debt)
-2.21-2.219.079.07174.15174.1584.6284.6283.1783.17
Net Cash Growth (YoY)
---89.29%-89.29%109.38%109.38%----
Net Cash Per Share
-0.00-0.000.020.010.610.320.560.351.762.38
Filing Date Shares Outstanding
856.7856.7856.7856.7551.86551.86239.9239.9145.72145.72
Total Common Shares Outstanding
856.7856.7856.7856.7551.86551.86239.9239.9145.72145.72
Working Capital
180.84180.846.376.37182.31182.3187.9887.98138.42138.42
Book Value Per Share
0.210.210.230.230.360.360.840.840.950.95
Tangible Book Value
180.88180.88180.41180.41180.41180.4188.0688.06138.37138.37
Tangible Book Value Per Share
0.210.210.210.210.330.330.370.370.950.95
Machinery
0.020.020.020.020.020.02----
SEC Filings: 10-K · 10-Q